Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

The Changing Fortunes of Antibacterial Drug Development and Commercialization

  • Broadcast in Science
  • 0 comments
IQPC_NYC

IQPC_NYC

×  

Follow This Show

If you liked this show, you should follow IQPC_NYC.
h:86805
s:850520
archived
Tune in as IQPC_NYC interviews Chris Thomson, PhD, Director of Licensing & Business Development at Astellas Pharma Europe Ltd. and speaker at the Anti-Infectives Summit, Jan 25-27 in Philadelphia. For more info, visit anti-infectivesummit.com.

Comments

 comments